Suven life sciences secures 4 (four) Product Patents for their NCE's in Australia, Eurasia, Israel and USA
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated May 23, 2016 titled "Suven life sciences secures 4 (four) Product Patents for their NCE's in Australia, Eurasia, Israel and USA". Board Meeting Intimation for Results & Closure of Trading Window
Suven Life Sciences Ltd has informed BSE that a Board Meeting of the Company will be held on May 27, 2016, inter alia, to consider and take on record the following matters:- To consider and approve the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2016.Further, that TRADING WINDOW for dealing in the securities of the Company was closed from May 18, 2016 to May 29, 2016 (both days inclusive).... Shareholding for the Period Ended March 31, 2016
Suven Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Suven Life Sciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Suven to Present at Bio-Europe Spring 2016 conference being held at Stockholm, Sweden
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated April 04, 2016 titled "Suven to Present at Bio-Europe Spring 2016 conference being held at Stockholm, Sweden". Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jasti Property and Equity Holdigns Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Suven Life Sciences gets patents for neurodegenerative disease drug
With these new patents, Suven has 20 granted patents from China, 16 from Eurasia and 19 from Hong Kong Suven Life Sciences secures three (3) Product Patents in China, Eurasia and Hong Kong
Suven Life Sciences Ltd has informed BSE regarding a Press Release dated March 14, 2016, titled "Suven Life Sciences secures three (3) Product Patents in China, Eurasia and Hong Kong". Investors Meet
Suven Life Sciences Ltd has informed BSE regarding Investors Meet on 10th & 11th March, 2016. Investor Conference Call on March 08, 2016
Suven Life Sciences Ltd has informed BSE regarding "Investor Conference Call on March 08, 2016".